Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chen HM
------>authors3_c=None
------>paper_class1=1
------>Impact_Factor=None
------>paper_class3=2
------>paper_class2=1
------>vol=40
------>confirm_bywho=curator
------>insert_bywho=tmtsai00
------>Jurnal_Rank=None
------>authors4_c=None
------>comm_author=1
------>patent_EDate=None
------>authors5_c=None
------>publish_day=None
------>paper_class2Letter=None
------>page2=637
------>medlineContent=
------>unit=F0400
------>insert_date=20040413
------>iam=7
------>update_date=None
------>author=???
------>change_event=5
------>ISSN=None
------>authors_c=None
------>score=500
------>journal_name=oral oncology
------>paper_name=Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy
------>confirm_date=20040422
------>tch_id=084014
------>pmid=15063392
------>page1=630
------>fullAbstract=Previous studies have shown a selective accumulation of 5-aminolevulinic acid (ALA)-derived protoporphrin IX (PpIX) in oral premalignant and malignant tissues. This provides a biologic rationale for the clinical use of ALA-mediated PDT (ALA-PDT) for oral premalignant and malignant lesions. In this study, five patients with oral verrucous hyperplasia (OVH) were treated with a new protocol of ALA-PDT composed of multiple 3-min irradiations with a light emitting diode (LED) red light at 635+/-5 nm separated with several 3-min rests for a total of 1000 s (fluence rate, 100 mW/cm(2); light exposure dose, 100 J/cm(2)) after topical application of 20% ALA for 1.5 or 2 h. Topical ALA-PDT was repeated once a week until the complete regression of the lesion. Complete regression of all OVH lesions was observed after 1-3 treatments (average, 2 treatments) of topical ALA-PDT. At an average follow-up of 5.6 months (range, 3-11 months), all the five OVH patients were free of tumor recurrence. We conclude that topical ALA-PDT with fractionated irradiations by an LED red light at 635+/-5 nm is an effective and successful treatment modality for OVH.
------>tmu_sno=None
------>sno=8302
------>authors2=Chen CT
------>authors3=Yang H
------>authors4=Kuo MYP
------>authors5=Kuo YS
------>authors6=Lan WH, Wang YP, Tsai T*, Chiang CP*
------>authors6_c=None
------>authors=Chen HM
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=None
------>publish_area=None
------>updateTitle=Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2004
------>submit_flag=None
------>publish_month=None
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z